Ajay Srivastava DVM.MS.PhD

As an accomplished nutraceutical researcher and strategic leader with advanced degrees in medical pharmacology and over 20 years of experience in innovation and product development, I have developed over 200 formulations for pet and human health, including several patented and patent-pending technologies currently commercialized. My entrepreneurial mindset and strategic leadership skills have resulted in substantial growth and revenue generation from technologies developed under my guidance. I have successfully collaborated with CROs and universities domestically and internationally, and I now lead a team of veterinarians, scientists, and nutritionists in R&D and product development.

Additionally, I co-manage a cross-functional team in regulatory affairs and marketing. I have successfully conducted and supervised several preclinical and clinical efficacy studies in the human and pet nutraceutical space. I currently lead and manage all the new and existing label claims, medical substantiation, toxicology, and GRAS studies.

My passion is developing and maintaining relationships with key stakeholders, including clients, suppliers, contract manufacturers, regulatory authorities, and KOLs.

I am the editor of the world's first comprehensive book on pet and human nutraceuticals, and most importantly, I am committed and passionate about what I do.

• The first researcher showed dietary melatonin and resveratrol's neuroprotective and antioxidant efficacy in trauma-induced epilepsy.
• Editor of two books on nutraceuticals in veterinary medicine and human health. Author of more than 20 book chapters on nutraceuticals.
• More than a dozen issued and pending patents on nutraceuticals and nutritional products.
• Founder of Nutraceutra LLC, a comprehensive nutraceutical and nutrition health consulting firm.
• Cofounder: Anivive, A California-based biotech company.

• Founding member veterinary cannabis society
• Executive member of the research and education committee. of VCS.
• Founding member of the Animal health supplement council
• Scientific sessions chair of WVC, NASC, AVMA, Indian pharmacology association, and many more.

Srivastava A, Lall R, Talukder J, DuBourdieu D, Gupta RC. Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases. Molecules. 2019;24(23):4289

 Srivastava A, Gupta RC, Doss RB, Lall R. Trace Minerals, Vitamins and Nutraceuticals in Prevention and Treatment of COVID-19. J Diet Suppl. 2022;19(3):395-429. 

 Prasad S, DuBourdieu D, Srivastava A, Kumar P, Lall R. Metal-Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin. Int J Mol Sci. 2021 Jun 30;22(13):7094.

 DuBourdieu D, Talukder J, Srivastava A, Lall R, Panchal S, Kothari C, Gupta RC. Efficacy of TurmiZn, a Metallic Complex of Curcuminoids-Tetrahydrocurcumin and Zinc on Bioavailability, Antioxidant, and Cytokine Modulation Capability. Molecules. 2023 Feb 9;28(4):1664. 

Srivastava AK, Malhotra J, Gupta YK. Adenosine receptors do not mediate the melatonin protection against pentylenetetrazole-induced induced seizures in rats. Neurobiology (Bp), 9(3-4):147-52, 2001.

Srivastava AK, Gupta SK, Jain S, Gupta YK. Effect of melatonin and phenytoin on an intracortical ferric chloride model of posttraumatic seizures in rats. Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):145-9.

Gupta RC, Lall R, Srivastava A, Sinha A. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Front Vet Sci. 2019 Jun 25;6:192.

Gupta YK, Chaudhary G, Srivastava AK. Protective effect of resveratrol against pentylenetetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology. 65(3):170-4, 2002.

Gupta YK, Verrendra Kumar MH, Srivastava AK. Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition, and oxidative stress in rats. Pharmacol Biochem Behav. 74(3):579-85, 2003.

Rachael E. Webber1, Ramesh C. Gupta1, Robin B. Doss1, Jean Miller, Terry D. Canerdy, Laura K. Hoffman1, Ajay Srivastava , Rajiv Lall Therapeutic Efficacy and Safety Evaluation of Flex ChoiceTM in Moderately Osteoarthritic Dogs. International journal of veterinary health sciences and research.

 Rajiv Lall, Ajay k Srivastava, Ramesh C Gupta. A Randomized, Blinded, Placebo-Controlled Study Of BVP-01, A Proprietary Nutraceutical Formulation For The Treatment Of Canine Osteoarthritis. International journal of veterinary health sciences and research.

1. Ovotransferrin treatment for the reproductive tract: Patent number: 10905748 

2. Oral Delivery Compositions for improved gut barrier protection  and Immunity in Mammals: Publication number: 20190336546 

3. Oral delivery compositions for treating dermatitis disorders in mammals: Patent number: 10406232 

4. Dental hard chew supplements containing antimicrobial actives: Patent number: 9968548

1.Nutraceuticals: Efficacy, Safety and Toxicity 2nd Edition

Ramesh C. Gupta (Editor), Rajiv Lall (Editor), Ajay Srivastava (Editor) Elsevier publication.

2. Nutraceuticals in Veterinary Medicine 1st ed. 2019 Edition

by Ramesh C. Gupta (Editor), Ajay Srivastava (Editor), Rajiv Lall (Editor) Springer publication

1. The Art of nutraceutical product development 2018, NASC, annual meeting Scottsdale Arizona

2. Cognitive Decline in Aging Pets: Are Nutraceuticals Effective 2014. National Animal Supplement Council meeting in Tampa, Florida

3. In Vitro, preclinical and clinical trials for new supplement Innovation.

4. Obesity in pets: what is the solution?  Global Pet Expo in Orlando, Florida.

BIOGUT: A patented probiotic technology for pet gastrointestinal health (commercialized)

PORCELAIN: A patented nutraceutical technology for periodontal disease. (patented and commercialized)

CERAMACHEW: A patented ceramide-based based nutraceutical product for dry skin and autoimmune skin condition atopic dermatitis in Pets ( Patented)

ITPGS: A patent-pending technology on egg-derived protein and vitamin E derivative for gut health and enhanced bioavailability. ( Commercialized)

TURMIZN: A patent-pending technology of highly bio-available metal complex of curcuminoids and zinc. (commercialized)

ADEPPT:    A Patent pending technology using egg-derived biopeptide and chitopolysaaachride for its antimicrobial, anti-inflammatory, and immune-modulating role. ( Commercialized)